Having worked in the food industry I know that there is no set method of determining shelf life and it is up to the producer to chose what "use by" or "best before" dates they want to put on their stock, based on their own view of the product under normal conditions
From a pharmacological standpoint, several considerations are relevant: Gastrointestinal effects : Retatrutide, like other GLP-1-based therapies, commonly causes nausea, vomiting, diarrhoea, and reduced appetite
Importantly, no severe treatment-related adverse effects were documented across any trial
it's about preserving the integrity of complex amino acid chains to ensure your study's data is valid and reproducible
In a 2025 review, Sikiric and his team report that the study found the peptide was safe and well-tolerated, but they have not published the data
Starting with lower concentrations and gradually increasing helps identify your personal tolerance